Catalyst Event
Biogen Inc (BIIB) · Other
From KEDI Tesla Fixed Tech100 Index (KTSLT100)
3/20/2026, 12:00:00 AM
An appeals panel in the U.K. ruled on March 20, 2026, that the National Institute for Health and Care Excellence (NICE) must reconsider its previous negative recommendation against the reimbursement of the Alzheimer's drug Leqembi (lecanemab). This event is estimated to have a medium impact due to the potential for expanded market access.
Korean Translation
2026년 3월 20일, 영국 항소 패널은 국립보건임상연구원(NICE)이 알츠하이머 치료제 레켐비(레카네맙)에 대한 이전의 부정적인 급여 권고를 재고해야 한다고 판결함. 시장 접근성 확대 가능성으로 중간 수준의 영향이 예상됨.
Related Recent Events
Micron Technology Inc. (MU) · Earnings Release
Micron's fiscal third-quarter 2026 earnings release is scheduled for June 24, 2026, scheduled. High importance is estimated as earnings releases for major semiconductor companies typically result in price impacts exceeding 10%.
6/24/2026, 12:00:00 AM
Apple Inc (AAPL) · Other
Apple's annual Worldwide Developers Conference (WWDC) is scheduled to begin on June 8, 2026, to unveil iOS 27 and major AI advancements; these updates are estimated to have a >5% price impact scheduled
6/8/2026, 12:00:00 AM
Palo Alto Networks Inc (PANW) · Earnings Release
Palo Alto Networks' next earnings release for Q3 2026 is scheduled for May 19, 2026. Low importance as it is a routine scheduled announcement with no results yet, scheduled.
5/19/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Next earnings release for Q1 2026 is scheduled for 2026-05-14, with analysts forecasting an EPS of -$0.04. A neutral impact is expected as the market typically waits for actual results, so the release is forecasted and scheduled.
5/14/2026, 12:00:00 AM
AppLovin Corporation (APP) · Earnings Release
AppLovin's Q1 2026 earnings release is scheduled. Analysts forecast EPS of $3.41. Medium importance is estimated as earnings releases typically drive significant volatility scheduled.
5/13/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
Q1 2026 earnings release scheduled for May 5, 2026. The company guided for Q1 revenue of approximately $9.8 billion, representing ~32% year-over-year growth but a sequential decline. Analysts forecast EPS of ~$1.27. Medium market impact as a major quarterly catalyst expected.
5/5/2026, 12:00:00 AM